Jessica Guarnaschelli
Independent Consultant JNG International
Seminars
Wednesday 25th February 2026
Panel Discussion: Strategizing Your Preclinical Program to Remove Obstacles for Your Phase Zero or FIH Trial
11:00 am
- Using early biodistribution and dosimetry to guide safe, effective dosing for phase zero/fih trials
- Confirming target specificity preclinically to reduce off-target risks and strengthen your IND package
- Aligning radiochemistry with GMP standards early to avoid delays and ensure clinical readiness
